Optimal Anti-Platelet Treatment for Patients With Stent IMplantation And Clopidogrel Low Response: OPTIMAL Study
Phase of Trial: Phase IV
Latest Information Update: 07 Mar 2018
Price : $35 *
At a glance
- Drugs Ticagrelor (Primary) ; Aspirin; Cilostazol; Clopidogrel
- Indications Coronary artery disease; Coronary stent thrombosis
- Focus Pharmacodynamics
- Acronyms OPTIMAL
- 31 Aug 2018 Biomarkers information updated
- 16 Mar 2016 Status changed from not yet recruiting to recruiting, according to ClinicalTrials.gov record.
- 16 Mar 2016 Planned End Date changed from 1 Dec 2015 to 1 Dec 2016, according to ClinicalTrials.gov record.